179 related articles for article (PubMed ID: 8569218)
1. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Beaughard M; Brasset M; John G; Massingham R
J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
[TBL] [Abstract][Full Text] [Related]
2. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
3. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
[TBL] [Abstract][Full Text] [Related]
4. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
J Clin Invest; 1989 Jul; 84(1):18-27. PubMed ID: 2661588
[TBL] [Abstract][Full Text] [Related]
5. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
[TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
8. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
[TBL] [Abstract][Full Text] [Related]
9. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
Yao SK; Ober JC; Gonenne A; Clubb FJ; Krishnaswami A; Ferguson JJ; Anderson HV; Gorecki M; Buja LM; Willerson JT
Circ Res; 1993 Nov; 73(5):952-67. PubMed ID: 8403265
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
[TBL] [Abstract][Full Text] [Related]
11. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Kirchengast M; Rübsamen K; Lehmann HD
J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
[TBL] [Abstract][Full Text] [Related]
13. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
Pimenov LT; Ezhov AV; Churshin AD
Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
[No Abstract] [Full Text] [Related]
14. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
[TBL] [Abstract][Full Text] [Related]
15. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
Soward AL; Vanhaleweyk GL; Serruys PW
Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Urquhart J; Epstein SE; Patterson RE
Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
[TBL] [Abstract][Full Text] [Related]
17. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation.
Golino P; Ambrosio G; Pascucci I; Ragni M; Russolillo E; Chiariello M
Thromb Haemost; 1992 Mar; 67(3):302-5. PubMed ID: 1641819
[TBL] [Abstract][Full Text] [Related]
18. Are calcium antagonists cardioprotective?
Kendall MJ; Horton RC
J R Coll Physicians Lond; 1985 Apr; 19(2):85-9. PubMed ID: 3889321
[No Abstract] [Full Text] [Related]
19. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Nearing BD; Hutter JJ; Verrier RL
J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
[TBL] [Abstract][Full Text] [Related]
20. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]